Demystifying Mesothelioma: Understanding Its Characteristics

Demystifying Mesothelioma: Understanding Its Characteristics

In a new article, researchers explore the complicated world of mesothelioma. This cutting-edge research sheds light on why it is so hard to identify and characterize mesothelioma. It offers invaluable insights into the latest advancements in understanding this disease.

Exploring New Diagnosis and Classification

Mesothelioma is a type of cancer that affects the lining of certain organs, like the lungs and chest wall. It is linked to exposure to asbestos, a harmful substance found in some workplaces and buildings. This cancer can take a long time to show up after someone has been exposed to asbestos, sometimes even decades.

There are four types of malignant mesothelioma: Pleural, peritoneal, pericardial and testicular. Pleural mesothelioma affects the outer lining of the lungs and chest wall. It represents about 75% of all cases. Peritoneal mesothelioma affects the abdomen and represents about 23%. Incidences of cases in the lining of the testis and the heart represent about 1% each.

To understand mesothelioma, it’s important to look at its features. Doctors use a mix of clinical information and imaging tests like CT scans to diagnose it. If they see thickening of the lining on these scans, it’s often a sign of mesothelioma.

One big challenge with mesothelioma is telling it apart from other types of cancer that may have spread to the same areas. But recent research has found a promising way to help with this. By using certain markers in lab tests—like HEG1 and claudin-4 staining—doctors can better tell if a tumor is mesothelioma or something else. Yet, they still need to be careful, especially when dealing with certain types of lung cancer.

Unfortunately, there isn’t a specific test yet that can easily identify sarcomatoid mesothelioma. But other lab tests can help doctors figure out if a growth is likely to be cancerous or not. These tests look for things like BAP1, MTAP, and NF2/Merlin.

Cracking the Code of Mesothelioma

Doctors have also learned about a stage of mesothelioma called mesothelioma in situ. This stage involves changes in the cells lining the organs, but they haven’t spread beyond that layer. It’s important because it helps doctors understand how mesothelioma develops over time and how it can be treated.

Understanding the different characteristics of mesothelioma is really important. It is critical for diagnosing and treating it properly. New advancements in medical technology are helping doctors diagnose mesothelioma more accurately and at an earlier stage. This can improve a patient’s chances of survival.

Mesothelioma doesn’t just affect the person who has it—it can also have a big impact on their loved ones and the community. While mesothelioma can be tricky to diagnose, ongoing research is helping doctors get better at spotting it early and treating it effectively. By learning more about mesothelioma and working together to prevent asbestos exposure, we can improve outcomes for people affected by this cancer. Collaboration between scientists, doctors, and policymakers is key to fighting mesothelioma and keeping people safe.

Source:

Churg, Andrew. “Mesothelioma: Morphologic and Immunohistochemical Findings.” Pathologie (Heidelberg, Germany), April 3, 2024. https://doi.org/10.1007/s00292-024-01317-6.

Similar Posts

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • |

    Mesothelioma Victims’ Victory in Pennsylvania

    Workers and their families have won a victory in Pennsylvania after the state Supreme Court ruled that they could sue former employers over late-manifesting industrial diseases like mesothelioma. The decision focused on a provision in Pennsylvania’s Workers’ Compensation Act that says workers cannot sue an employer if their occupational disease occurred more than 300 weeks after their on-the-job exposure. While many occupational injuries and diseases occur within weeks or months of exposure to a toxin, asbestos diseases like mesothelioma are a notable exception. Believed to be caused by chronic irritation from inhaled or ingested asbestos fibers, mesothelioma does not usually begin to cause symptoms until at least a decade after exposure. Expressing the opinion of the majority, Supreme Court Justice…

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…